Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2020 Feb 18;221(5):715-720.
doi: 10.1093/infdis/jiz507.

Cytomegalovirus Genetic Diversity Following Primary Infection

Affiliations
Clinical Trial

Cytomegalovirus Genetic Diversity Following Primary Infection

Shannon A Ross et al. J Infect Dis. .

Abstract

Background: Infection with multiple cytomegalovirus (CMV) strains (mixed infection) was reported in a variety of hosts. As the virus genetic diversity in primary CMV infection and the changes over time remain incompletely defined, we examined CMV diversity and changes in diversity over time in healthy adolescent females who participated in a phase 2 CMV gB/MF59 vaccine trial.

Methods: CMV genetic diversity was determined by genotyping of 5 genes-gB (UL55), gH (UL75), gN (UL73), US28, and UL144-in urine, saliva, and plasma samples from 15 study subjects.

Results: At the time of primary infection, 5 of 12 (42%) urine samples had multiple virus strains, and 50% of vaccine recipients were infected with gB1 genotype (vaccine strain). Mixed infection was documented in all 15 subjects within 3 months after primary infection, and the majority had different CMV genotypes in different compartments. Changes in genotypes over time were observed in all subjects.

Conclusions: Infection with multiple CMV genotypes was common during primary infection and further diversification occurred over time. Infection with gB1 genotype in vaccine recipients suggests a lack of strain-specific protection from the vaccine. As only 5 polymorphic genes were assessed, this study likely underestimated the true genetic diversity in primary CMV infection.

Keywords: cytomegalovirus; diversity; primary infection; strains.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Percentage of subjects with mixed infection at the time of primary infection (month 0, urine) and longitudinally (urine, saliva, and plasma).

References

    1. Britt W. Cytomegalovirus. In: Remington JS, Klein JO, Wilson CB, Baker CJ, eds. Infectious diseases of the fetus and newborn infant. 7th ed Philadelphia: W.B. Saunders Company, 2011:704–53.
    1. Dollard SC, Grosse SD, Ross DS. New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection. Rev Med Virol 2007; 17:355–63. - PubMed
    1. Stratton KR, Durch JS, Lawrence RS, eds. Vaccines for the 21st century: a tool for decision making. Washington, DC: National Academies Press, 2000. - PubMed
    1. Renzette N, Gibson L, Jensen JD, Kowalik TF. Human cytomegalovirus intrahost evolution—a new avenue for understanding and controlling herpesvirus infections. Curr Opin Virol 2014; 8:109–15. - PMC - PubMed
    1. Görzer I, Kerschner H, Jaksch P, et al. . Virus load dynamics of individual CMV-genotypes in lung transplant recipients with mixed-genotype infections. J Med Virol 2008; 80:1405–14. - PubMed

Publication types

MeSH terms